The translation of genetic information to The translation of genetic information to proteins forms the basis for most metabolic proteins forms the basis for most metabolic processes in the body. When these molprocesses in the body. When these molecules are required, genes are transcribed ecules are required, genes are transcribed first to the corresponding messenger ribofirst to the corresponding messenger ribonucleic acids (mRNAs) and then translated nucleic acids (mRNAs) and then translated to their protein counterparts. Additional to their protein counterparts. Additional protein diversity is introduced by subseprotein diversity is introduced by subsequent processes of post-translational quent processes of post-translational modification (e.g. phosphorylation, glycomodification (e.g. phosphorylation, glycosylation), resulting in the biological phenosylation), resulting in the biological phenotype. This process of transcription, type. This process of transcription, translation and post-translational moditranslation and post-translational modification is variable, depending on genetic fication is variable, depending on genetic predispositions and environmental interpredispositions and environmental interactions. Thus, the previous notion that actions. Thus, the previous notion that one gene results in one protein no longer one gene results in one protein no longer holds true. Indeed it has been estimated holds true. Indeed it has been estimated that, if the human genome contains that, if the human genome contains 30 000 expressed genes, there may be the 30 000 expressed genes, there may be the potential to express as many as one million potential to express as many as one million different proteins. Bearing this in mind, the different proteins. Bearing this in mind, the prospect of identifying what is now termed prospect of identifying what is now termed the 'proteome' (the protein complement of the 'proteome' (the protein complement of a genome (Wasinger a genome (Wasinger et al et al, 1995) ) is daunt-, 1995)) is daunting. Fortunately, the birth of 'proteomics', ing. Fortunately, the birth of 'proteomics', an umbrella term encompassing the many an umbrella term encompassing the many tools available to investigate proteins tools available to investigate proteins expressed within cells, fluids, tissues or expressed within cells, fluids, tissues or organisms, has made this task more organisms, has made this task more manageable. These proteomic methods manageable. These proteomic methods have the power to display and quantify have the power to display and quantify the functional expression of genes, enabling the functional expression of genes, enabling the measurement of disease-associated or the measurement of disease-associated or phenotypic changes in proteins. phenotypic changes in proteins.
Proteomic studies thus have the potenProteomic studies thus have the potential to provide important insights into our tial to provide important insights into our understanding of psychiatric, neurounderstanding of psychiatric, neurodegenerative and neurological diseases. degenerative and neurological diseases. For example, by identifying alterations in For example, by identifying alterations in protein expression in post-mortem brain protein expression in post-mortem brain they can provide new insights into the they can provide new insights into the cellular mechanism underlying diseases cellular mechanism underlying diseases such as schizophrenia. Likewise, by characsuch as schizophrenia. Likewise, by characterising disease-associated protein profiles terising disease-associated protein profiles in sera they may be able to identify and in sera they may be able to identify and quantify proteins that serve as diagnostic quantify proteins that serve as diagnostic or prognostic markers. Furthermore, or prognostic markers. Furthermore, proteomic investigation of the effects of proteomic investigation of the effects of pharmaceutical agents pharmaceutical agents in vitro in vitro may help may help us to identify new therapeutic pathways. us to identify new therapeutic pathways. In this context, it is of interest to discuss In this context, it is of interest to discuss how exactly these 'proteomic' techniques how exactly these 'proteomic' techniques might be relevant to a psychiatric disease, might be relevant to a psychiatric disease, for example, schizophrenia. Schizophrenia, for example, schizophrenia. Schizophrenia, with its early developmental and later with its early developmental and later degenerative/atrophic components, is a degenerative/atrophic components, is a particularly complex disorder. We know particularly complex disorder. We know that multiple, largely unidentified genetic that multiple, largely unidentified genetic (Weinberger (Weinberger et al et al, 2001) and environmental , 2001 ) and environmental (Cannon (Cannon et al et al, 2003) risk factors interact to , 2003) risk factors interact to lead to disease and disease progression lead to disease and disease progression (Thompson (Thompson et al et al, 2001) . However, the , 2001). However, the underlying functional changes at the underlying functional changes at the cellular level remain unknown. This is cellular level remain unknown. This is where the strength of a proteomics apwhere the strength of a proteomics approach lies, allowing one to identify, quanproach lies, allowing one to identify, quantify and compare the levels of thousands of tify and compare the levels of thousands of proteins. The main methods encompassed proteins. The main methods encompassed within this term can be broadly described within this term can be broadly described as those using two-dimensional gel electroas those using two-dimensional gel electrophoresis and those using non-gel-based phoresis and those using non-gel-based methods to separate and identify proteins methods to separate and identify proteins in a complex mixture, such as a whole cell in a complex mixture, such as a whole cell or tissue lysate. or tissue lysate.
GEL-BASED PROTEOMIC GEL-BASED PROTEOMIC METHODS METHODS
Gel-based methods are the most commonly Gel-based methods are the most commonly used and well-defined techniques in the used and well-defined techniques in the proteomic world, having been around since proteomic world, having been around since the mid-1970s (O'Farrell, 1975 . Briefly, the mid-1970s (O'Farrell, 1975) . Briefly, two-dimensional gel electrophoresis intwo-dimensional gel electrophoresis involves volves the separation of solubilised proteins the separation of solubilised proteins in the first dimension according to their in the first dimension according to their charge (isoelectric point, p charge (isoelectric point, pI I), followed by ), followed by their separation in the second dimension their separation in the second dimension by sodium dodecyl sulphate-polyacrylby sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), amide gel electrophoresis (SDS-PAGE), according to their relative molecular mass according to their relative molecular mass (M (M r r ). The resulting protein 'maps' can then ). The resulting protein 'maps' can then be compared using image analysis software be compared using image analysis software and subsequent statistical analysis to idenand subsequent statistical analysis to identify protein spots of interest (Fig. 1) . In tify protein spots of interest (Fig. 1) . In addition, a mass spectrometry approach, addition, a mass spectrometry approach, for example matrix-assisted laser desorpfor example matrix-assisted laser desorption/ionisation mass spectrometry, which tion/ionisation mass spectrometry, which measures peptide masses based on their measures peptide masses based on their mass-to-charge ratio, generates spectra that mass-to-charge ratio, generates spectra that can be used to search for correlating protein can be used to search for correlating protein identities in sequence databases. These identities in sequence databases. These techniques and the newer two-dimensional techniques and the newer two-dimensional fluorescence difference gel electrophoresis fluorescence difference gel electrophoresis method, which allows two samples labelled method, which allows two samples labelled with different fluors to be resolved on the with different fluors to be resolved on the same gel, have been used in post-mortem same gel, have been used in post-mortem studies of human brain tissue in schizostudies of human brain tissue in schizophrenia, bipolar disorder and major depresphrenia, bipolar disorder and major depression (Edgar sion (Edgar et al et al, 1999; Johnston-Wilson , 1999; Johnston-Wilson et et al al, 2000; Prabakaran , 2000; Prabakaran et al et al, 2004) . , 2004). A recent study investigated schizo-A recent study investigated schizophrenia using post-mortem brain tissue at phrenia using post-mortem brain tissue at the transcriptome, metabolome and prothe transcriptome, metabolome and proteome level (Prabakaran teome level (Prabakaran et al et al, 2004) . This , 2004) . This approach highlights the complementary approach highlights the complementary role of proteomics in validating and prorole of proteomics in validating and providing additional information on postviding additional information on posttranslational processing to transcriptomic translational processing to transcriptomic investigations. Two-dimensional fluoresinvestigations. Two-dimensional fluorescence difference gel electrophoresis was cence difference gel electrophoresis was used to compare protein expression in preused to compare protein expression in prefrontal cortical tissue taken from 10 frontal cortical tissue taken from 10 controls and 10 individuals with schizocontrols and 10 individuals with schizophrenia. The combined findings strongly phrenia. The combined findings strongly suggest a mitochondrial dysfunction within suggest a mitochondrial dysfunction within this area of the brain in schizophrenia. Prothis area of the brain in schizophrenia. Proteomics was invaluable in leading to this teomics was invaluable in leading to this conclusion, with almost 50% of the differconclusion, with almost 50% of the differentially expressed proteins being associated entially expressed proteins being associated with mitochondrial function or oxidative with mitochondrial function or oxidative stress. In support of this, our recent twostress. In support of this, our recent twodimensional gel electrophoresis study of dimensional gel electrophoresis study of the anterior cingulate cortex in schizothe anterior cingulate cortex in schizophrenia, bipolar disorder and major depresphrenia, bipolar disorder and major depression also revealed abnormal expression of sion also revealed abnormal expression of many proteins with roles in metabolism many proteins with roles in metabolism and mitochondrial function (Pennington and mitochondrial function (Pennington et et al al, 2004) .
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, 2004).
NON-GEL-BASED NON-GEL-BASED PROTEOMIC METHODS PROTEOMIC METHODS
Gel-based methods have fundamental Gel-based methods have fundamental limitations due to their inability to limitations due to their inability to represent the whole proteome. For examrepresent the whole proteome. For example, although brain tissue is the most comple, although brain tissue is the most complex tissue in the body with regard to plex tissue in the body with regard to heterogeneity of protein content, the averheterogeneity of protein content, the average two-dimensional gel can resolve only age two-dimensional gel can resolve only a few thousand proteins, and many of these a few thousand proteins, and many of these represent different post-translationally represent different post-translationally modified forms of a much smaller number modified forms of a much smaller number of gene products. Alternative approaches of gene products. Alternative approaches avoid the use of gels altogether by avoid the use of gels altogether by combining liquid chromatography and combining liquid chromatography and mass spectrometry. In these 'shotgun' promass spectrometry. In these 'shotgun' proteomics approaches, the sample is separated teomics approaches, the sample is separated by one or more dimensions of liquid chroby one or more dimensions of liquid chromatography to reduce the complexity of matography to reduce the complexity of peptide fractions. These are subsequently peptide fractions. These are subsequently introduced into a tandem mass spectrointroduced into a tandem mass spectrometer for sequence-based identification. meter for sequence-based identification. v. control, where there control, where there is a 'light' reagent tag and a 'heavy' reagent is a 'light' reagent tag and a 'heavy' reagent tag to label total tryptic peptides generated tag to label total tryptic peptides generated from the two samples. The combined from the two samples. The combined sample then undergoes single or multisample then undergoes single or multidimensional chromatography, and resuldimensional chromatography, and resultant peptide mass peaks from mass tant peptide mass peaks from mass spectrometry clearly show the two samples spectrometry clearly show the two samples separated by the mass of the two tags, separated by the mass of the two tags, allowing relative quantitation. This method allowing relative quantitation. This method has been used to study changes in protein has been used to study changes in protein expression in a cortical neuron cell culture expression in a cortical neuron cell culture undergoing DNA damage-induced death, undergoing DNA damage-induced death, where 150 proteins were identified and where 150 proteins were identified and quantitated (Johnson quantitated (Johnson et al et al, 2004) . Forty-, 2004) . Fortyfive per cent of these had altered expression five per cent of these had altered expression in the damaged neurons; validation was in the damaged neurons; validation was carried out for 14 of these, mostly cytocarried out for 14 of these, mostly cytoskeletal proteins and those involved in skeletal proteins and those involved in energy production and oxidative stress, energy production and oxidative stress, using Western blots and immunohistousing Western blots and immunohistochemistry. chemistry.
In addition, there is much interest in the In addition, there is much interest in the development of antibody and protein development of antibody and protein arrays for quantitative expression profiling, arrays for quantitative expression profiling, but considerable work remains to be but considerable work remains to be carried out before this approach can be carried out before this approach can be routinely used in proteomic investigations routinely used in proteomic investigations (Cutler, 2003) . One chip-based method (Cutler, 2003) . One chip-based method that has already had a major impact on that has already had a major impact on the discovery of potential biomarkers, the discovery of potential biomarkers, especially in cancer research, is surfaceespecially in cancer research, is surfaceenhanced laser desorption ionisation (SELDI) enhanced laser desorption ionisation (SELDI) coupled with time-of-flight mass spectrocoupled with time-of-flight mass spectrometry (Petricoin metry (Petricoin et al et al, 2002) . In this , 2002). In this approach a small volume of a liquid approach a small volume of a liquid sample, typically a body fluid such as sample, typically a body fluid such as serum, plasma or urine, is spotted onto a serum, plasma or urine, is spotted onto a chemically modified surface of a special chemically modified surface of a special target. Using this approach it is possible target. Using this approach it is possible to rapidly screen large numbers of samples to rapidly screen large numbers of samples to detect disease-associated proteins, but a to detect disease-associated proteins, but a major disadvantage is that it provides no major disadvantage is that it provides no direct information on the identities of these direct information on the identities of these components. Nevertheless, this identificacomponents. Nevertheless, this identification may not be required. For example, tion may not be required. For example, using bioinformatics, Petricoin using bioinformatics, Petricoin et al et al (2002) used SELDI mass spectral patterns (2002) used SELDI mass spectral patterns to discriminate normal serum samples from to discriminate normal serum samples from samples taken from patients with early samples taken from patients with early ovarian cancer. Identification of disease ovarian cancer. Identification of disease occurred in nearly 100% of cases. Howoccurred in nearly 100% of cases. However, re-analysis of these data has led to a ever, re-analysis of these data has led to a questioning of the validity of this technique questioning of the validity of this technique (Check, 2004) and has raised many meth- (Check, 2004) and has raised many methodological issues that need clarification odological issues that need clarification before the technique can be applied to before the technique can be applied to the investigation of neurological and the investigation of neurological and psychiatric disorders. psychiatric disorders.
CREATING A SUB -PROTEOME CREATING A SUB -PROTEOME It is of interest to fractionate samples at the It is of interest to fractionate samples at the cellular and sub-cellular level to increase cellular and sub-cellular level to increase proteomic coverage so that specific and less proteomic coverage so that specific and less abundant subsets of the total proteome can abundant subsets of the total proteome can be analysed. Laser-assisted micro-dissection be analysed. Laser-assisted micro-dissection allows the isolation of regions of interest allows the isolation of regions of interest that cannot be dissected by the naked eye, that cannot be dissected by the naked eye, for example a sub-region of the hippocamfor example a sub-region of the hippocampus. This method has been successfully pus. This method has been successfully applied to the investigation of pancreatic applied to the investigation of pancreatic cancer by Shekouh cancer by Shekouh et al et al (2003) who (2003) who removed tumour cells from surrounding removed tumour cells from surrounding tissue and performed two-dimensional gel tissue and performed two-dimensional gel electrophoresis and mass spectrometry electrophoresis and mass spectrometry identifying a novel tumour-associated identifying a novel tumour-associated protein, S100A6. protein, S100A6.
The sub-fractionation of homogenised The sub-fractionation of homogenised brain samples allows isolation of membrane, brain samples allows isolation of membrane, mitochondrial or nuclear proteins. In addimitochondrial or nuclear proteins. In addition, proteins can be isolated that have tion, proteins can be isolated that have undergone specific post-translational modifiundergone specific post-translational modifications, such as phosphorylated proteins. cations, such as phosphorylated proteins. When combined, such techniques result in When combined, such techniques result in decreased sample heterogeneity and thus indecreased sample heterogeneity and thus increase the likelihood of gaining information crease the likelihood of gaining information about proteins of potential interest. about proteins of potential interest.
P E NNING TON E T A L P E NNIN G TON E T A L WHICH SAMPLES CAN WHICH SAMPLES CAN WE USE ? WE USE ?
Most proteomic research into psychiatric Most proteomic research into psychiatric disorders has focused on the comparative disorders has focused on the comparative analysis of post-mortem brain tissue. This analysis of post-mortem brain tissue. This tissue has limitations in terms of differentissue has limitations in terms of differentiating primary and secondary pathology. tiating primary and secondary pathology. Therefore, other tissues must also be Therefore, other tissues must also be investigated in order to obtain a fuller investigated in order to obtain a fuller picture of disease-associated changes in picture of disease-associated changes in protein profiles. Fortunately, proteomic protein profiles. Fortunately, proteomic techniques can be applied to whatever techniques can be applied to whatever sample is of interest, for example animal sample is of interest, for example animal models and drug action effects models and drug action effects in vitro in vitro. . Furthermore, with the advent of the fractioFurthermore, with the advent of the fractionation techniques described previously, it nation techniques described previously, it will also be possible to study cerebrospinal will also be possible to study cerebrospinal fluid (CSF) or plasma and serum samples, fluid (CSF) or plasma and serum samples, fluids containing several high-abundance fluids containing several high-abundance proteins of little interest, such as albumin. proteins of little interest, such as albumin. In addition to providing insights into the In addition to providing insights into the disease process, studying CSF using proteodisease process, studying CSF using proteomic methods may allow researchers to gain mic methods may allow researchers to gain further insights into drug action and effect. further insights into drug action and effect. A two-dimensional gel study looking at the A two-dimensional gel study looking at the CSF of individuals with schizophrenia CSF of individuals with schizophrenia found an average 21% decrease in the found an average 21% decrease in the number of proteins detected in those receivnumber of proteins detected in those receiving haloperidol compared with CSF from ing haloperidol compared with CSF from the same individuals after withdrawal of the same individuals after withdrawal of treatment (Johnson treatment (Johnson et al et al, 1992) . , 1992). The role of proteomics in psychiatric reThe role of proteomics in psychiatric research is clear. It provides researchers with search is clear. It provides researchers with a set of tools to help validate and expand a set of tools to help validate and expand on both genetic and epigenetic studies in on both genetic and epigenetic studies in order to explore further the pathogenesis order to explore further the pathogenesis of disease. As this holistic approach is of disease. As this holistic approach is largely non-hypothesis based, it should largely non-hypothesis based, it should reveal aspects of abnormal function reveal aspects of abnormal function previously inaccessible to researchers. In previously inaccessible to researchers. In addition, from a clinical viewpoint, diagaddition, from a clinical viewpoint, diagnostic biomarkers may be revealed through nostic biomarkers may be revealed through analysis of serum or CSF. These biomarkers analysis of serum or CSF. These biomarkers will hopefully facilitate the identification of will hopefully facilitate the identification of those at risk of psychosis, and treatment those at risk of psychosis, and treatment response may also be predicted. We look response may also be predicted. We look forward to the clinical improvements that forward to the clinical improvements that should follow the application of proteomic should follow the application of proteomic methods to psychiatric and neurological methods to psychiatric and neurological disorders. disorders.
